Publications

Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems. J Maj, Z Rogóz
Journal of neural transmission (Vienna, Austria : 1996),
PMID:10226939
Monday, 21 June 1999
A partial agonist at strychnine-insensitive glycine sites facilitates spatial learning in aged rats. P Popik, Z Rygielska
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
PMID:10210162
Monday, 21 June 1999
Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine. I Nalepa, D H Manier, D D Gillespie, S P Rossby, D E Schmidt, F Sulser
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
PMID:9716317
Tuesday, 25 May 1999
Neurohypophyseal peptides and social recognition in rats. P Popik, J M van Ree
Progress in brain research,
PMID:10074804
Monday, 29 March 1999
Contribution of the glycine site of NMDA receptors in rostral and intermediate-caudal parts of the striatum to the regulation of muscle tone in rats. E Lorenc-Koci, J Konieczny, S Wolfarth
Brain research,
PMID:9630698
Monday, 29 March 1999
Effect of mild chronic stress, as a model of depression, on the immunoreactivity of C57BL/6 mice. M Kubera, A Basta-Kaim, V Holan, A Simbirtsev, A Roman, N Pigareva, E Prokopieva, J Sham
International journal of immunopharmacology,
PMID:9877287
Thursday, 18 March 1999
Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol. A Pinna, J Wardas, A Cozzolino, M Morelli
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
PMID:9885784
Monday, 15 March 1999
Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. P Popik, J Mamczarz, M Fraczek, M Widła, M Hesselink, W Danysz
Neuropharmacology,
PMID:9833632
Friday, 26 February 1999
LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats. J Konieczny, K Ossowska, S Wolfarth, A Pilc
Naunyn-Schmiedeberg's archives of pharmacology,
PMID:9826074
Thursday, 14 January 1999
GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. W Danysz, C G Parsons, M Karcz-Kubicha, A Schwaier, P Popik, K Wedzony, J Lazarewicz, G Quack
Amino acids,
PMID:9871467
Wednesday, 13 January 1999